Possible underlying mechanisms linking CAD to cognitive dysfunctions include neurotrophic biomarkers such as brain-derived neurotrophic factor (BDNF), and insulin-like growth factor-1 (IGF-1). This evidence concerns the gene IGF1 and coronary artery disorder.